Regulations.gov document
Evaluation of Gastric pH-Dependent Drug Interactions With Acid-Reducing Agents: Study…
Other · FDA-2020-D-1794 · posted Mar 13, 2023
Key facts
| Document ID | FDA-2020-D-1794-0011 |
|---|---|
| Title | Evaluation of Gastric pH-Dependent Drug Interactions With Acid-Reducing Agents: Study Design, Data Analysis, and Clinical Implications; Guidance for Industry; Final Guidance |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2020-D-1794 |
| Posted | Mar 13, 2023 |
| Comment period opens | Mar 13, 2023 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: